Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,155 | 33,612 | 64,144 | 55,643 | 63,207 |
| Marketable Securities | 68,324 | 62,750 | 50,809 | 70,452 | 73,790 |
| Receivables | 820 | 1,089 | 1,924 | 1,696 | 10,000 |
| Other current assets | 0 | 0 | 0 | 0 | 1,768 |
| TOTAL | $98,226 | $102,634 | $121,235 | $131,532 | $152,783 |
| Non-Current Assets | |||||
| PPE Net | 24,398 | 25,395 | 26,676 | 27,710 | 29,111 |
| Investments And Advances | 10,014 | 23,264 | 24,039 | 36,959 | 32,115 |
| Other Non-Current Assets | 28,912 | 29,132 | 30,257 | 30,039 | 29,534 |
| TOTAL | $63,324 | $77,791 | $80,972 | $94,708 | $90,760 |
| Total Assets | $161,550 | $180,425 | $202,207 | $226,240 | $243,543 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,300 | 5,163 | 4,176 | 3,992 | 5,950 |
| Accrued Expenses | 5,861 | 5,659 | 3,648 | 6,171 | 5,459 |
| TOTAL | $14,638 | $17,173 | $12,881 | $14,960 | $13,610 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,332 | 3,926 | 2,751 | 3,513 | 2,201 |
| Other Non-Current Liabilities | 43,055 | 43,647 | 44,321 | 44,953 | 42,502 |
| TOTAL | $47,880 | $48,149 | $50,369 | $50,865 | $50,301 |
| Total Liabilities | $62,518 | $65,322 | $63,250 | $65,825 | $63,911 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,417 | 9,391 | 9,390 | 9,389 | 9,368 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -333,804 | -315,743 | -289,973 | -266,586 | -245,387 |
| Other shareholders' equity | 214 | 177 | 264 | 268 | 574 |
| TOTAL | $99,032 | $115,103 | $138,957 | $160,415 | $179,632 |
| Total Liabilities And Equity | $161,550 | $180,425 | $202,207 | $226,240 | $243,543 |